Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
152 Avinguda de la Generalitat , Sant Cugat del Vallès, CT, 08174, ES
Grifols Partnership is a CDMO focused on added value injectable products, with a large international experience in the development and manufacturing of sterile drug products (small molecules) in glass vials and PP bags. Strict compliance with global manufacturing standards has earned us the highest accreditations, including authorizations by the U.S. FDA, EU and U.S. GMP and authorization for parametric release sterility.
The company has now announced a total of $15 million for expansions of these U.S. facilities.
By: Patrick Lavery
The CDMO is preparing for its New Jersey facility to become fully operational this year.
Will create a dual-site manufacturing network in Taiwan and the United States.
By: Charlie Sternberg
Positions North America as a strategic focus area.
Aim to create a scalable, place of care manufacturing platform that reduces facility requirements and lowers production costs.
As an embedded CMO, we leverage decades of expertise, collaboration and best-in-class facilities to provide you with an integrated, end-to-end solution.
Released By AbbVie Contract Manufacturing
New 460,000 sq.-ft. campus will serve as a hub for U.S. Manufacturing Operations.
By: Kristin Brooks
Expanded facility integrates Syngoi Technologies’ enzymatic DNA platform into Artis’ North American operations.
21,000-sq.-ft. lab adds dedicated suites and HEPA filtered cleanrooms to support development and bioengineering research.
The new building is part of a CHF 1.4 billion site investment to advance human model systems.
Charles City expansion will add a new API plant with 140,000 liters of capacity and $30M expansion in Milan will add new analytical development and process R&D capabilities.
Will increase commercial capacity, expand R&D capabilities, and support continued demand for U.S.-based drug product manufacturing.
The general inspection included tours of the warehouse, manufacturing plant, and analytical laboratories.
Site has produced hundreds of distinct bioconjugates and supports clinical, commercial, and non‑GMP manufacturing activities.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
